ISL1 and metastatic malignant neoplasm in the lymph nodes: As depicted in Table 1, GC patients with diffuse type, lymph node metastasis, vascular invasion, and distant metastasis exhibited higher expression levels of ISL1 than those without these characteristics (P < 0.001 for all parameters).